322 related articles for article (PubMed ID: 19675450)
21. Subgroups of non-atypical hyperplasia of breast defined by proliferation of oestrogen receptor-positive cells.
Iqbal M; Davies MP; Shoker BS; Jarvis C; Sibson DR; Sloane JP
J Pathol; 2001 Mar; 193(3):333-8. PubMed ID: 11241412
[TBL] [Abstract][Full Text] [Related]
22. Papillary lesions of the breast.
Ibarra JA
Breast J; 2006; 12(3):237-51. PubMed ID: 16684322
[TBL] [Abstract][Full Text] [Related]
23. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms.
Raju UB; Lee MW; Zarbo RJ; Crissman JD
Mod Pathol; 1989 Nov; 2(6):569-76. PubMed ID: 2479944
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic evaluation of papillary lesions of the breast on core biopsy.
Pathmanathan N; Albertini AF; Provan PJ; Milliken JS; Salisbury EL; Bilous AM; Byth K; Balleine RL
Mod Pathol; 2010 Jul; 23(7):1021-8. PubMed ID: 20473278
[TBL] [Abstract][Full Text] [Related]
25. Oestrogen receptor expression in the normal and pre-cancerous breast.
Shoker BS; Jarvis C; Sibson DR; Walker C; Sloane JP
J Pathol; 1999 Jul; 188(3):237-44. PubMed ID: 10419589
[TBL] [Abstract][Full Text] [Related]
26. Estrogen receptor expression in benign breast ductal cells obtained from random periareolar fine needle aspiration correlates with menopausal status and cytomorphology index score.
Sharma P; Kimler BF; Warner C; Metheny T; Xue Q; Zalles CM; Fabian CJ
Breast Cancer Res Treat; 2006 Nov; 100(1):71-6. PubMed ID: 16791479
[TBL] [Abstract][Full Text] [Related]
27. The diagnostic utility of CK5/6 and p63 in fine-needle aspiration of the breast lesions diagnosed as proliferative fibrocystic lesion.
Al-Maghraby H; Ghorab Z; Khalbuss W; Wong J; Silverman JF; Saad RS
Diagn Cytopathol; 2012 Feb; 40(2):141-7. PubMed ID: 22246930
[TBL] [Abstract][Full Text] [Related]
28. Ductal carcinoma in situ with spindle cells: a potential diagnostic pitfall in the evaluation of breast lesions.
Tan PH; Lui GG; Chiang G; Yap WM; Poh WT; Bay BH
Histopathology; 2004 Oct; 45(4):343-51. PubMed ID: 15469472
[TBL] [Abstract][Full Text] [Related]
29. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile.
Chivukula M; Haynik DM; Brufsky A; Carter G; Dabbs DJ
Am J Surg Pathol; 2008 Nov; 32(11):1721-6. PubMed ID: 18769331
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of estrogen receptors in columnar cell change and in unfolding breast lobules.
Tremblay G; Deschênes J; Alpert L; Quenneville LA
Breast J; 2005; 11(5):326-32. PubMed ID: 16174153
[TBL] [Abstract][Full Text] [Related]
31. A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion.
Man YG; Shen T; Weisz J; Berg PE; Schwartz AM; Mulshine JL; Sang QX; Nieburgs HE
Cancer Detect Prev; 2005; 29(4):323-31. PubMed ID: 16122886
[TBL] [Abstract][Full Text] [Related]
32. Papillary transitional cell carcinoma of the breast: a report of five cases with distinction from eccrine acrospiroma.
Mooney EE; Tavassoli FA
Mod Pathol; 1999 Mar; 12(3):287-94. PubMed ID: 10102614
[TBL] [Abstract][Full Text] [Related]
33. Papillary lesions of the breast: selected diagnostic and management issues.
Collins LC; Schnitt SJ
Histopathology; 2008 Jan; 52(1):20-9. PubMed ID: 18171414
[TBL] [Abstract][Full Text] [Related]
34. A comparison of immunohistochemical staining for oestrogen receptor, progesterone receptor and HER-2 in breast core biopsies and subsequent excisions.
Wood B; Junckerstorff R; Sterrett G; Frost F; Harvey J; Robbins P
Pathology; 2007 Aug; 39(4):391-5. PubMed ID: 17676479
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical differentiation of atypical hyperplasia vs. carcinoma in situ of the breast.
Masood S; Sim SJ; Lu L
Cancer Detect Prev; 1992; 16(4):225-35. PubMed ID: 1281040
[TBL] [Abstract][Full Text] [Related]
36. Comparison of immunohistochemical staining in breast papillary neoplasms of cytokeratin 5/6 and p63 in core needle biopsies and surgical excisions.
Koo JS; Kim MJ; Kim EK; Park BW
Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):108-15. PubMed ID: 22553810
[TBL] [Abstract][Full Text] [Related]
37. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision.
Wagoner MJ; Laronga C; Acs G
Am J Clin Pathol; 2009 Jan; 131(1):112-21. PubMed ID: 19095574
[TBL] [Abstract][Full Text] [Related]
38. CK5 is more sensitive than CK5/6 in identifying the "basal-like" phenotype of breast carcinoma.
Bhargava R; Beriwal S; McManus K; Dabbs DJ
Am J Clin Pathol; 2008 Nov; 130(5):724-30. PubMed ID: 18854264
[TBL] [Abstract][Full Text] [Related]
39. Spontaneous mammary intraepithelial lesions in dogs--a model of breast cancer.
Antuofermo E; Miller MA; Pirino S; Xie J; Badve S; Mohammed SI
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2247-56. PubMed ID: 17982119
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical staining for cyclin D1 and Ki-67 aids in the stratification of atypical ductal hyperplasia diagnosed on breast core biopsy.
Hameed O; Ghali VS; Tartter PI; Mizrachi H
Am J Clin Pathol; 2005 Dec; 124(6):862-72. PubMed ID: 16416735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
